Is a complete TCRX research report available?

No complete published report is available for TScan Therapeutics, Inc. (TCRX) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

TScan Therapeutics, Inc. (TCRX)

NASDAQ: TCRX · USD

$0.20

+0.01 (+4.2%)· Recorded snapshot

Market cap	13.6M
Revenue (ttm)	7.1M
Net income (ttm)	-117.7M
EPS (ttm)	-$1.74
Shares out	67.8M
Volume	356,246
Beta	1.14

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 7.1M
Net income (ttm): -117.7M
EPS (ttm): -$1.74
Market cap: 13.6M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	持有

Metric	Value
Amount currency	USD
CIK code	0001783328
Company name	TScan Therapeutics, Inc.
Country	United States
Country code	US
CUSIP number	89854M101
Earnings date	2026-11-11
Earnings time	bmo
Employees	138
Employees change	-72
Employees growth	-34.29%
Enterprise value	$4.3M
Exchange	NASDAQ
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	2018
Industry	Biotechnology
IPO date	2021-07-16
Is primary listing	Yes
Is SPAC	No
ISIN number	US89854M1018
Last 10-K release date	2026-03-04
Last earnings date	2026-08-12
Last refreshed	2026-10-28
Last stock split type	Never
Market cap	$13.6M
Market cap category	Nano-Cap
Next earnings date	2026-11-11
Options	No
Price	$0.20
Price currency	USD
Sector	Healthcare
SIC code	2836
Stock price date	2026-10-28
Symbol	TCRX
U.S. state	Massachusetts
Website	https://www.tscan.com

Metric

Value

Amount currency

USD

CIK code

0001783328

Company name

TScan Therapeutics, Inc.

Country

United States

Country code

CUSIP number

89854M101

Earnings date

2026-11-11

Earnings time

bmo

Employees

138

Employees change

-72

Employees growth

-34.29%

Enterprise value

$4.3M

Exchange

NASDAQ

Financial currency

USD

Financial report date

2026-06-30

First seen

2026-05-09

Fiscal year end

December

Founded

2018

Industry

Biotechnology

IPO date

2021-07-16

Is primary listing

Yes

Is SPAC

ISIN number

US89854M1018

Last 10-K release date

2026-03-04

Last earnings date

2026-08-12

Last refreshed

2026-10-28

Last stock split type

Never

Market cap

$13.6M

Market cap category

Nano-Cap

Next earnings date

2026-11-11

Options

Price

$0.20

Price currency

USD

Sector

Healthcare

SIC code

2836

Stock price date

2026-10-28

Symbol

TCRX

U.S. state

Massachusetts

Website

https://www.tscan.com

Metric	Value
Earnings yield	-868.35%
EV/Sales	0.53x
FCF / EV yield	-3,157.85%
FCF yield	-910.12%
Forward EV/Sales	2.43x
Forward P/S	8.41x
P/B ratio	0.19x
P/S ratio	1.83x
Price / tangible book value	0.19x
Sector forward P/E	23.56x
Sector P/E	50.13x

Metric

Value

Earnings yield

-868.35%

EV/Sales

0.53x

FCF / EV yield

-3,157.85%

FCF yield

-910.12%

Forward EV/Sales

2.43x

Forward P/S

8.41x

P/B ratio

0.19x

P/S ratio

1.83x

Price / tangible book value

0.19x

Sector forward P/E

23.56x

Sector P/E

50.13x

Metric	Value
Operating margin	-1,667.02%
Pretax margin	-1,655.35%
Profit per employee	$-852,986
Revenue per employee	$51,529
ROA	-31.53%
ROA (5Y)	-25.19%
ROCE	-84.38%
ROE	-95.8%
ROE (5Y)	-62.64%
ROIC	-34.2%
SBC / revenue	138.39%

Metric

Value

Operating margin

-1,667.02%

Pretax margin

-1,655.35%

Profit per employee

$-852,986

Revenue per employee

$51,529

ROA

-31.53%

ROA (5Y)

-25.19%

ROCE

-84.38%

ROE

-95.8%

ROE (5Y)

-62.64%

ROIC

-34.2%

SBC / revenue

138.39%

Metric	Value
EPS growth quarters	3
EPS growth years	6
Net income growth quarters	3
Net income growth years	0
Revenue growth	2.16%
Revenue growth (Q)	-65.83%
Revenue growth (QoQ)	7.03%
Revenue growth 3Y	-24.33%
Revenue growth 5Y	3.59%
Revenue growth years	1

Metric

Value

EPS growth quarters

EPS growth years

Net income growth quarters

Net income growth years

Revenue growth

2.16%

Revenue growth (Q)

-65.83%

Revenue growth (QoQ)

7.03%

Revenue growth 3Y

-24.33%

Revenue growth 5Y

3.59%

Revenue growth years

Metric	Value
Capital expenditures	$-2.2M
Depreciation and amortization	$2.9M
EBIT	$-118.5M
EBITDA	$-115.7M
EPS	$-1.74
FCF per share	$-1.75
Financing cash flow	$172,000
Free cash flow	$-118.4M
Free cash flow minus SBC	$-128.3M
Gross profit	$-88.3M
Investing cash flow	$46.9M
Net cash flow	$-69.2M
Net income	$-117.7M
Operating cash flow minus SBC	$-126.1M
Operating income	$-118.5M
Revenue	$7.1M
Stock-based compensation	$9.8M

Metric

Value

Capital expenditures

$-2.2M

Depreciation and amortization

$2.9M

EBIT

$-118.5M

EBITDA

$-115.7M

EPS

$-1.74

FCF per share

$-1.75

Financing cash flow

$172,000

Free cash flow

$-118.4M

Free cash flow minus SBC

$-128.3M

Gross profit

$-88.3M

Investing cash flow

$46.9M

Net cash flow

$-69.2M

Net income

$-117.7M

Operating cash flow minus SBC

$-126.1M

Operating income

$-118.5M

Revenue

$7.1M

Stock-based compensation

$9.8M

Metric	Value
Altman Z-Score	-5.87
Book value per share	$1.02
Debt / equity	1.32
Interest coverage	-42.5
Long-term assets	$67M
Long-term liabilities	$71.5M
Net cash (debt)	$9.3M
Net cash / market cap	71.18%
Net cash growth	-92.37%
Net debt / equity	-0.13
Piotroski F-Score	4
Property, plant and equipment	$62M
Shareholders' equity	$69M
Tangible book value	$69M
Tangible book value per share	$1.02
Total assets	$171.5M
Total cash	$100.2M
Total debt	$90.9M
Total liabilities	$102.4M
WACC	3.44%

Metric

Value

Altman Z-Score

-5.87

Book value per share

$1.02

Debt / equity

1.32

Interest coverage

-42.5

Long-term assets

$67M

Long-term liabilities

$71.5M

Net cash (debt)

$9.3M

Net cash / market cap

71.18%

Net cash growth

-92.37%

Net debt / equity

-0.13

Piotroski F-Score

Property, plant and equipment

$62M

Shareholders' equity

$69M

Tangible book value

$69M

Tangible book value per share

$1.02

Total assets

$171.5M

Total cash

$100.2M

Total debt

$90.9M

Total liabilities

$102.4M

WACC

3.44%

Metric	Value
Asset turnover	0.03
Current assets	$104.4M
Current liabilities	$31M
Current ratio	3.37
Net working capital	$-7.3M
Quick ratio	3.23
Working capital	$73.4M
Working capital turnover	0.05

Metric

Value

Asset turnover

0.03

Current assets

$104.4M

Current liabilities

$31M

Current ratio

3.37

Net working capital

$-7.3M

Quick ratio

3.23

Working capital

$73.4M

Working capital turnover

0.05

Metric	Value
Buyback yield / dilution	-19.44%
Dividend yield	0%
Shareholder yield	-19.44%

Metric

Value

Buyback yield / dilution

-19.44%

Dividend yield

Shareholder yield

-19.44%

Metric	Value
150-day SMA	$0.79
1D price change	4.17%
1M price change	-42.24%
1M total return	-42.24%
1W price change	-12.32%
1W total return	-12.32%
1Y price change	-91.39%
1Y return CAGR	-91.4%
1Y total return	-91.39%
20-day SMA	$0.24
200-day SMA	$0.86
3M price change	-74.44%
3M total return	-74.44%
3Y price change	-94.22%
3Y return CAGR	-61.34%
3Y total return	-94.22%
50-day SMA	$0.38
50-day SMA vs 200-day SMA	50under200
52-week high	$2.28
52-week high date	2025-10-28
52-week low	$0.18
52-week low date	2026-10-26
5Y price change	-97.62%
5Y return CAGR	-52.64%
5Y total return	-97.62%
6M price change	-85.01%
6M total return	-85.01%
All-time high	$14.71
All-time high date	2021-08-18
All-time low	$0.18
All-time low date	2026-10-26
Average true range (ATR)	$0.03
Average volume	591.3K
Beta (1Y)	3.13
Beta (2Y)	2.26
Beta (5Y)	1.14
Change from 52-week high	-91.23%
Change from 52-week low	11.11%
Change from all-time high	-98.66%
Change from all-time low	9.11%
Change from open	6.04%
Day's gap	-1.77%
Dollar volume	$71,249
High price	$0.20
Low price	$0.18
Monthly RSI	30.33
Open price	$0.19
Position in 52-week range	100%
Premarket change	-1.98%
Premarket close	$0.19
Premarket price	$0.19
Premarket volume	923
Previous close	$0.19
Price vs 150-day SMA	-75.23%
Price vs 20-day SMA	-17.17%
Price vs 200-day SMA	-77.19%
Price vs 50-day SMA	-48.56%
Relative volume	0.6
Return from IPO open	-98.4%
Return from IPO price	-98.72%
RSI	28.39
Sharpe ratio	-1.95
Sharpe ratio (3Y)	-0.6
Sharpe ratio (5Y)	-0.27
Sortino ratio	-2.32
Sortino ratio (3Y)	-0.77
Sortino ratio (5Y)	-0.34
Volume	356.2K
Weekly RSI	24.55
YTD price change	-80.36%
YTD total return	-80.36%

Metric

Value

150-day SMA

$0.79

1D price change

4.17%

1M price change

-42.24%

1M total return

-42.24%

1W price change

-12.32%

1W total return

-12.32%

1Y price change

-91.39%

1Y return CAGR

-91.4%

1Y total return

-91.39%

20-day SMA

$0.24

200-day SMA

$0.86

3M price change

-74.44%

3M total return

-74.44%

3Y price change

-94.22%

3Y return CAGR

-61.34%

3Y total return

-94.22%

50-day SMA

$0.38

50-day SMA vs 200-day SMA

50under200

52-week high

$2.28

52-week high date

2025-10-28

52-week low

$0.18

52-week low date

2026-10-26

5Y price change

-97.62%

5Y return CAGR

-52.64%

5Y total return

-97.62%

6M price change

-85.01%

6M total return

-85.01%

All-time high

$14.71

All-time high date

2021-08-18

All-time low

$0.18

All-time low date

2026-10-26

Average true range (ATR)

$0.03

Average volume

591.3K

Beta (1Y)

3.13

Beta (2Y)

2.26

Beta (5Y)

1.14

Change from 52-week high

-91.23%

Change from 52-week low

11.11%

Change from all-time high

-98.66%

Change from all-time low

9.11%

Change from open

6.04%

Day's gap

-1.77%

Dollar volume

$71,249

High price

$0.20

Low price

$0.18

Monthly RSI

30.33

Open price

$0.19

Position in 52-week range

100%

Premarket change

-1.98%

Premarket close

$0.19

Premarket price

$0.19

Premarket volume

923

Previous close

$0.19

Price vs 150-day SMA

-75.23%

Price vs 20-day SMA

-17.17%

Price vs 200-day SMA

-77.19%

Price vs 50-day SMA

-48.56%

Relative volume

0.6

Return from IPO open

-98.4%

Return from IPO price

-98.72%

RSI

28.39

Sharpe ratio

-1.95

Sharpe ratio (3Y)

-0.6

Sharpe ratio (5Y)

-0.27

Sortino ratio

-2.32

Sortino ratio (3Y)

-0.77

Sortino ratio (5Y)

-0.34

Volume

356.2K

Weekly RSI

24.55

YTD price change

-80.36%

YTD total return

-80.36%

Metric	Value
Float	54.4M
Float percentage	80.2%
Shares change (QoQ)	12.78%
Shares change (YoY)	19.44%
Shares held by insiders	0.18%
Shares held by institutions	63.36%
Shares outstanding	67.8M
Short % of float	4.57%
Short % of shares	3.67%
Short ratio	1.9 days

Metric

Value

Float

54.4M

Float percentage

80.2%

Shares change (QoQ)

12.78%

Shares change (YoY)

19.44%

Shares held by insiders

0.18%

Shares held by institutions

63.36%

Shares outstanding

67.8M

Short % of float

4.57%

Short % of shares

3.67%

Short ratio

1.9 days

TScan Therapeutics, Inc. (TCRX)

Price

Financial snapshot

Fair-value bridge

Latest news · TCRX

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All TCRX indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on TCRX

Frequently asked questions